Neprilysin: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
== Neprilysin == | |||
[[File:Kidney_cd10_ihc.jpg|thumb|right|Immunohistochemical staining of neprilysin in kidney tissue.]] | |||
Neprilysin | '''Neprilysin''', also known as [[CD10]] or neutral endopeptidase, is a zinc-dependent metalloprotease enzyme that is involved in the degradation of various peptides. It is expressed in a variety of tissues, including the [[kidney]], [[lung]], and [[central nervous system]]. Neprilysin plays a crucial role in the regulation of peptide hormones and is implicated in several physiological and pathological processes. | ||
== | == Structure and Function == | ||
Neprilysin | Neprilysin is a type II transmembrane protein that consists of a short cytoplasmic tail, a single transmembrane domain, and a large extracellular domain that contains the active site. The enzyme requires zinc as a cofactor for its catalytic activity, which involves the cleavage of peptide bonds on the amino side of hydrophobic residues. | ||
Neprilysin is responsible for the breakdown of several bioactive peptides, including [[enkephalins]], [[substance P]], [[bradykinin]], and [[atrial natriuretic peptide]]. By degrading these peptides, neprilysin regulates their levels and modulates their physiological effects, such as pain perception, blood pressure regulation, and fluid balance. | |||
== Clinical Significance == | |||
Neprilysin has been studied extensively in the context of [[cardiovascular disease]] and [[Alzheimer's disease]]. In the cardiovascular system, neprilysin degrades natriuretic peptides, which are involved in the regulation of blood pressure and fluid homeostasis. Inhibition of neprilysin, in combination with angiotensin receptor blockers, has been shown to be beneficial in the treatment of heart failure, as it enhances the effects of natriuretic peptides. | |||
In the [[central nervous system]], neprilysin is involved in the degradation of [[amyloid-beta]] peptides, which are implicated in the pathogenesis of Alzheimer's disease. Reduced neprilysin activity has been associated with increased amyloid-beta accumulation and plaque formation in the brain. | |||
== | == Expression and Regulation == | ||
Neprilysin expression is regulated by various factors, including [[hormones]], [[cytokines]], and [[growth factors]]. It is expressed in a wide range of tissues, with particularly high levels in the [[kidney]], where it is involved in the regulation of sodium and water balance. | |||
== | == Related Pages == | ||
* [ | * [[CD10]] | ||
* [[Metalloprotease]] | |||
* [[Zinc-dependent enzymes]] | |||
* [[Cardiovascular disease]] | |||
* [[Alzheimer's disease]] | |||
[[Category: | [[Category:Enzymes]] | ||
[[Category:Proteases]] | |||
[[Category:Human proteins]] | [[Category:Human proteins]] | ||
Latest revision as of 10:48, 15 February 2025
Neprilysin[edit]
Neprilysin, also known as CD10 or neutral endopeptidase, is a zinc-dependent metalloprotease enzyme that is involved in the degradation of various peptides. It is expressed in a variety of tissues, including the kidney, lung, and central nervous system. Neprilysin plays a crucial role in the regulation of peptide hormones and is implicated in several physiological and pathological processes.
Structure and Function[edit]
Neprilysin is a type II transmembrane protein that consists of a short cytoplasmic tail, a single transmembrane domain, and a large extracellular domain that contains the active site. The enzyme requires zinc as a cofactor for its catalytic activity, which involves the cleavage of peptide bonds on the amino side of hydrophobic residues.
Neprilysin is responsible for the breakdown of several bioactive peptides, including enkephalins, substance P, bradykinin, and atrial natriuretic peptide. By degrading these peptides, neprilysin regulates their levels and modulates their physiological effects, such as pain perception, blood pressure regulation, and fluid balance.
Clinical Significance[edit]
Neprilysin has been studied extensively in the context of cardiovascular disease and Alzheimer's disease. In the cardiovascular system, neprilysin degrades natriuretic peptides, which are involved in the regulation of blood pressure and fluid homeostasis. Inhibition of neprilysin, in combination with angiotensin receptor blockers, has been shown to be beneficial in the treatment of heart failure, as it enhances the effects of natriuretic peptides.
In the central nervous system, neprilysin is involved in the degradation of amyloid-beta peptides, which are implicated in the pathogenesis of Alzheimer's disease. Reduced neprilysin activity has been associated with increased amyloid-beta accumulation and plaque formation in the brain.
Expression and Regulation[edit]
Neprilysin expression is regulated by various factors, including hormones, cytokines, and growth factors. It is expressed in a wide range of tissues, with particularly high levels in the kidney, where it is involved in the regulation of sodium and water balance.
